STAT+: Flush with cash from Covid-19 vaccine, BioNTech founders have outsized ambitions

After the Covid-19 vaccine, BioNTech founders Ugur Sahin and Ozlem Tureci want to create a new kind of drug company.

BOSTON — BioNTech CEO Uğur Şahin had been in marathon meetings since he arrived in this city three days earlier, but if his energy had flagged it didn’t show. The clock had not even struck 8 a.m., and there was Şahin, in front of a table at the Four Seasons strewn with continental breakfast, deep in discussion with HIV expert Bruce Walker of the Ragon Institute.

Before Walker left, Şahin asked a reporter, newly arrived, to snap a photo of them to commemorate the moment.

Continue to STAT+ to read the full story…